Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 20, 2018
Pharmacy Choice - News - U.S. Pharmaceutical Industry - July 20, 2018

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/20/18 - "Silyl Etherified Derivatives of 5-Azacytidines in Carbohydrate Moiety" in Patent Application Approval Process (USPTO 20180179246)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Sako, Magoichi; SUGIYAMA, Shinpei, filed on February 22, 2018, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Ohara Pharmaceutical Co. L
7/20/18 - Aradigm Corp. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Jul. 3, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aradigm Corp. was posted on July 3, 2018. The SEC file number is 0001123292-18-000849.. A U.S. Securities and Exchange Commission filing is a formal document or
7/20/18 - Aradigm Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jul. 3, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aradigm Corp. was posted on July 3, 2018. The SEC file number is 0001123292-18-000850.. A U.S. Securities and Exchange Commission filing is a formal document or
7/20/18 - At first glance
At first glance, last week s decision by Pfizer to postpone price hikes seemed like a victory in the fight to reduce the crushing costs of medications. Pfizer said it will defer price increases until the end of 2018, or when Trump s so-called drug-price blueprint goes into effect whichever comes first. Experts suggest any change is u
7/20/18 - Bioclonetics Immunotherapeutics, Inc. Files SEC Form C/A, Offering Statement: (Jun. 28, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Bioclonetics Immunotherapeutics, Inc. was posted on June 28, 2018. The SEC file number is 0001665160-18-000627.. A U.S. Securities and Exchange Commission filin
7/20/18 - Cytotoxic Drug Market Research by 2025: Top Players Like Takeda, Novartis, Celgene, Sanofi, Eisai, Merck, Roche, Eli Lilly: worldwide Cytotoxic Drug Market Report is the more professional in-depth of this market is providers the status and forecast,
New York, NY 07/19/2018 The Top key vendors in Cytotoxic Drug Market include are Roche, Eli Lilly, Celgene, Sanofi, eisai, Sumitomo Dainippon Pharma, Merck, Seattle Genetics, Takeda, Haosoh Pharma, Novartis, AstraZeneca, Jazz Pharma, Spectrum Pharma. You Can Download Free Sample Copy of Cytotoxic Drug Market at...
7/20/18 - Dr. Reddy's Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market
HYDERABAD, India& PRINCETON, N.J. Dr. Reddy s Laboratories Ltd. today announced the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg, an over-the-counter therapeutic equivalent generic version of Nexium 24 HR Capsules in the United States market as approved by the U.S. Food and Drug Administration. The combined market
7/20/18 - FDA Issues Statement on Contaminated Illegal Synthetic Cannabinoid Products
The U.S. Department of Health and Human Services' Food and Drug Administration issued the following statement by Commissioner Scott Gottlieb regarding the health risks of contaminated illegal synthetic cannabinoid products:. "The U.S. Food and Drug Administration has become aware of reports of severe illnesses and deaths resulting from the use of.
7/20/18 - Findings from Novartis Yields New Findings on Pharmaceutical Research (Continuous Single-Step Wet Granulation with Integrated in-Barrel-Drying)
By a News Reporter-Staff News Editor at Drug Week Fresh data on Drugs and Therapies- Pharmaceutical Research are presented in a new report. According to news originating from Basel, Switzerland, by NewsRx correspondents, research stated, "It was investigated if continuous wet granulation and drying could be combined in a twin-screw granulator wit
7/20/18 - Global Dietary Supplements Market to Generate US$ 220.3 Bn in 2022: The global dietary supplements market is primarily driven by increased consumer awareness for preventative healthcare along with aging population. Growing influence of media developm
Sarasota, FL 07/20/2018 "Dietary Supplements Market by Ingredients for Additional Supplements, Medicinal Supplements, and Sports Nutrition Applications- Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 2022". According to the report, global dietary supplements market valued at USD 132.8 billion in 2016 and is expected
7/20/18 - GNW-News: FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid (CSF) assays to support the improved diagnosis of Alzheimer's disease (english)
FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid assays to support the improved diagnosis of Alzheimer's disease. F. Hoffmann-La Roche Ltd/ FDA grants Breakthrough Device Designation for Roche's Elecsys cerebrospinal fluid assays to support the improved diagnosis of Alzheimer's disease. The Breakthrough Device...
7/20/18 - Intiva Biopharma Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jun. 29, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Intiva Biopharma Inc. was posted on June 29, 2018. The SEC file number is 0001214659-18-004623.. A U.S. Securities and Exchange Commission filing is a formal do
7/20/18 - Intiva Biopharma Inc. Files SEC Form 4/A, Statement of Changes in Beneficial Ownership of Securities: (Jul. 2, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Intiva Biopharma Inc. was posted on July 2, 2018. The SEC file number is 0001214659-18-004709.. A U.S. Securities and Exchange Commission filing is a formal doc
7/20/18 - Intiva Biopharma Inc. Files SEC Form 8-K, Current Report: (Jun. 29, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Intiva Biopharma Inc. was posted on June 28, 2018. The SEC file number is 0001493152-18-009398.. A U.S. Securities and Exchange Commission filing is a formal do
7/20/18 - Intiva Biopharma Inc. Files SEC Form EFFECT, Notice of Effectiveness: (Jun. 28, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Intiva Biopharma Inc. was posted on June 28, 2018. The SEC file number is. A U.S. Securities and Exchange Commission filing is a formal document or financial st
7/20/18 - Investigators at Bristol-Myers Squibb Discuss Findings in Drug Conjugates (Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by...
Our news journalists obtained a quote from the research from Bristol-Myers Squibb, "Top-down HDX allows detailed assessment of the residue-level deuterium content in the payload conjugation region. For more information on this research see: Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass...
7/20/18 - Investigators at New York Medical College Release New Data on Neuroblastomas (A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF,...
According to news reporting from Valhalla, New York, by NewsRx journalists, research stated, "A phase 3 randomized study demonstrated significantly improved outcome by adding immunotherapy with ch14.18 antibody to isotretinoin as post-consolidation therapy for high-risk neuroblastoma. Funders for this research include National Institutes of Health,
7/20/18 - Kyto Biopharma Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Jun. 28, 2018)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Kyto Biopharma Inc. was posted on June 28, 2018. The SEC file number is 0001654954-18-007123.. A U.S. Securities and Exchange Commission filing is a formal docu
7/20/18 - Patent Application Titled "Thin Film with Non-Self-Aggregating Uniform Heterogeneity and Drug Delivery Systems Made Therefrom" Published Online...
Patent Application Titled "Thin Film with Non-Self-Aggregating Uniform Heterogeneity and Drug Delivery Systems Made Therefrom" Published Online. By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors Yang, Robert K.; Fuisz, Richa
7/20/18 - Patent Issued for Process for Synthesizing Oxidized Lactam Compounds (USPTO 10011569)
By a News Reporter-Staff News Editor at Drug Week Alkermes Pharma Ireland Limited has been issued patent number 10011569, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Remenar, Julius F.; Blumberg, Laura Cook; Zeidan, Tarek A.. This patent was filed on April 10, 2017 and was pub
7/20/18 - Patent Issued for Real Time Nuclear Isotope Detection (USPTO 10012740)
By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventor Nunn, Adrian D., filed on August 11, 2017, was published online on July 3, 2018. The assignee for this patent, patent number 10012740, is Bracco Diagnostics Inc.. Reporter
7/20/18 - Pediatric study analyzes dietary supplement trends among children with Down syndrome
By a News Reporter-Staff News Editor at Genomics& Genetics Weekly WASHINGTON New research published in The Journal of Pediatrics finds 49 percent out of 1,167 surveyed participants of parents of children with Down syndrome give or have given supplements to their children in an effort to improve their health outcomes. Parents who supplement spen
7/20/18 - PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides
PureTech Health plc, a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut Axis, today announced that it has entered into a multiyear collaboration with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., to advance PureTech s milk-derived exosome platform technology for the oral administration of
7/20/18 - Reports Outline Vitamin D Deficiency Study Results from Providence Sacred Heart Medical Center (Vitamin D: Effects on human reproduction, pregnancy,...
Reports Outline Vitamin D Deficiency Study Results from Providence Sacred Heart Medical Center. According to news originating from Spokane, Washington, by NewsRx correspondents, research stated, "Pregnancy places exceptional demands on vitamin D and calcium availability; thus, their deficiencies during pregnancy threaten the woman and her fetus.
7/20/18 - Researchers from Department of Pathology Report Recent Findings in Hypervitaminosis (Can adverse effects of excessive vitamin D supplementation occur...
According to news reporting originating in Erie, Pennsylvania, by NewsRx editors, the research stated, "Vitamin D is a fat-soluble hormone that has endocrine, paracrine and autocrine functions. The news reporters obtained a quote from the research from the Department of Pathology, "Despite such wide use of artificial vitamin D supplements, serum le
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415